A pilot study on willingness to participate in future preventive HIV vaccine trials

Indian Journal of Medical Research

Volumn 124, Issue DEC., 2006, Pages 631-640

  Suhadev, Mohanarani ^a   Nyamathi, Adeline M ^b   Swaminathan, Soumya ^a   Venkatesan, P ^a   Sakthivel, M Raja ^a   Shenbagavalli, R ^a   Suresh, Anita ^a   Fahey, John L ^c  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

High risk groups; HIV vaccine trial concepts; India; Willingness to participate

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLACEBO; POLIOMYELITIS VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONSULTATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MONOGAMY; MULTICENTER STUDY; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT PARTICIPATION; PHASE 1 CLINICAL TRIAL; PILOT STUDY; POLIOMYELITIS; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SOCIAL BEHAVIOR; SOCIAL STATUS; STRUCTURED QUESTIONNAIRE; UNSAFE SEX; UNSPECIFIED SIDE EFFECT; VOLUNTEER; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ATTITUDE; CROSS-SECTIONAL STUDY; IMMUNOLOGY; KNOWLEDGE; PSYCHOLOGICAL ASPECT; SEXUAL DEVELOPMENT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS VACCINES; ATTITUDE; CLINICAL TRIALS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KNOWLEDGE; MALE; PILOT PROJECTS; SEX CHARACTERISTICS; SEXUAL BEHAVIOR;

EID: 34247126128     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. HIV/AIDS Indian Scenario: Estimation of HIV infections among adult population, 2004. New Delhi: National AIDS Control Organization; 2004.
2. Excler JL. AIDS Vaccine development perceptions, challenges and hopes. Indian J Med Res 2005; 121: 568-81.
3. Kunte A, Misra B, Paranjape R, Mansukhani N, Padbidri V, Gonjari S, et al. HIV Sero prevalence and awareness about AIDS among pregnant women in rural areas of Pune district, Maharastra, India. Indian J Med Res 1999 110: 115-22.
4. Jain MK, John TJ, Keusch GT. A review of human immunodefiency virus infection in India. J Acquir Immune Defic Syndr 1994; 7: 1185-94.
5. Pais P. HIV and India looking into the abyss. Trop Med Int Health 1996; 1: 295-304.
6. Solomon S, Kumarasamy N, Ganesh AK, Amalraj RE. Prevalence and risk factors of HIV-1 and HIV-2 infection in urban and rural areas in Tamilnadu. Int J STD AIDS 1998; 9: 98-103.
7. Future access to HIV vaccines. Report from a WHO-UNAIDS consultation, Geneva; October 2-3, 2000. AIDS 2001; 15: W27-44.
8. Esparya J, Burke D. Epidemiological considerations in planning HIV preventive vaccine trials. AIDS 2001; 15 (Suppl 5): S49-S57.
9. Koblin BA, Avrett S, Taylor PE, Stevens CE. Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE. J Acquir Immune Defic Syndr Hum Retroviral 1997; 15: 165-71.
10. Bartholous BN, MacQueen KM, Douglas JM Jr, Buchbinder S, Mckirnan D, Judson FN. Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16: 108-15.
11. Celentano DD, Beyrer C, Natpratan C, Eitumtrakul S, Sussman L, Renzullo PO, et al. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand. AIDS 1995; 9: 1079-83.
12. McGrath JW, Mafigiri D, Kamya M, George K, Senvewo R, Svilar G, et al. Developing AIDS vaccine trials educational program in Uganda. J Acquir Immune Defic Syndr 2001; 26: 176-81.
13. Kiwanuka N, Robb M, Kigozi G, Birx D, Phillips J, Wabwire-Mangen F, et al. Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials. Acquir Immune Defic Synd 2004; 36: 2721-5.
14. Koblin BA, Heagetry, P, Sheon A, Buchbinder S, Celum C, Douglas JM, et al. Readiness of high risk population in the HIV network for prevention trial to participate in HIV vaccine efficacy trials in the United States. AIDS 1998; 12: 785-93.
15. Harrison LH, do lago RF, Friedman RK, Rodrigues J, Santos EM, de Melo MF, et al. Incident HIV infection in a high risk, homosexual, male cohort in Rio de Janerio, Brazil. J Acquire Immuno Defic Syndr 1999; 21: 408-12.
16. Perisse AR, Schechter M, Moreira RI, do Lago RF, Santoro-Lopes G, Harrison LH, et al. Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janerio, Brazil. J Acquire Immune Defic Syndr 2000; 25: 459-63.
17. Sahay S, Mehendale S, Sane S, Brahme R, Brown A, Charron K, et al. Correlates of HIV vaccine trial participation: an Indian perspective. Vaccine 2005; 23: 1351-8.
18. McGrath JW, George K, Sviler G, Ihier E, Mafigiri D, Kabugo M, et al. Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan Military. J Acquir Immune Defic Syndr 2001; 27: 381-8.
19. Vlahov D, Astemborski J, Solomon L, Galai N, Basarab L, Nelson KE. Interest in HIV vaccines among injection drug users in Baltimore, Maryland. AIDS Res Hum Retroviruses 1994; 10 (Supp 2): S265-S8.
20. Strauss RP, Sengupta S, Kegeles S, McLellan E, Metzger D, Eyre S, et al. Willingness to volunteer in future preventive HIV vaccine trials. J Acquir Immune Defic Syndr 2001; 26: 63-71.
21. Ringwalt CL, Greene JM, Robertson M, McPheeters M. Twelve month prevalence of homelessness among adolescents in the United States. Am J Public Health 1998; 88: 1325-9.
22. Hom DL, Johnson JL, Mugyenyi P, Byaruhanga R Kityo C, Louglin A, et al. HIV-1 risk & vaccine acceptability in the Ugandan military. J Acquir Immune Defic Syndr 1997; 15: 375-80.
23. Jackson DJ, Martin HL, Bwago JJ, Nyange PM, Rakwar JP, Kashonga F, et al. Acceptability of HIV vaccine trials in high risk heterosexual cohorts in Mombasa, Kenya, AIDS 1995; 11: 1279-83.